Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 1 January 2020)


Open article in different language:  DE  |  FR  |  IT
Art. 21 Preconditions

1 Any per­son ap­ply­ing for a li­cence to trade in for­eign coun­tries must prove that:

a.
the fa­cil­it­ies op­er­ate a sys­tem to en­sure the phar­ma­ceut­ic­al qual­ity of medi­cin­al products and that the com­pany man­age­ment and staff in the in­di­vidu­al de­part­ments con­cerned take an act­ive part in this sys­tem;
b.
a Re­spons­ible Per­son in ac­cord­ance with Art­icle 23 is avail­able;
c.
the fa­cil­it­ies are or­gan­ised in an ap­pro­pri­ate way;
d.
a doc­u­ment­a­tion sys­tem is avail­able that com­prises the work­ing in­struc­tions, pro­cess de­scrip­tions and pro­to­cols of the rel­ev­ant pro­ced­ures in­volved in the activ­it­ies;
e.
due di­li­gence is ex­er­cised as de­scribed in Art­icle 22.

2 Swiss­med­ic may spe­cify fur­ther tech­nic­al re­quire­ments and de­tails.

3 The li­cence does not en­title the hold­er to is­sue man­u­fac­tur­ing or­ders.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden